Synonym: (5Z,9α,11α,15R)-9,11,15-Trihydroxy-17-phenyl-18,19,20-trinor-prost-5-en-1-oic acid; (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoic acid; PhXA 85
CAS Number: 41639-83-2
Empirical Formula (Hill Notation): C23H34O5
Molecular Weight: 390.51
MDL Number: MFCD08056084
Linear Formula: C23H34O5
Product Type: Chemical
| assay |
≥95% (HPLC) |
| color |
pale yellow, oil |
| InChI |
1S/C23H34O5/c24-18(13-12-17-8-4-3-5-9-17)14-15-20-19(21(25)16-22(20)26)10-6-1-2-7-11-23(27)28/h1,3-6,8-9,18-22,24-26H,2,7,10-16H2,(H,27,28)/b6-1-/t18-,19+,20+,21-,22+/m0/s1 |
| InChI key |
HNPFPERDNWXAGS-NFVOFSAMSA-N |
| optical activity |
[α]/D 26.0 to 36.0°, c = 0.1 in methanol |
| originator |
Johnson & Johnson |
| Quality Level |
100  |
| shipped in |
wet ice |
| SMILES string |
O[C@H](CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=C/CCCC(O)=O)CCc2ccccc2 |
| solubility |
DMSO: freely soluble |
| |
methanol: soluble |
| storage temp. |
−20°C |
| Biochem/physiol Actions: |
Potent, selective FP prostanoid receptor agonist, F-series prostaglandin analog. 200 times as potent as isopropyl ester form. |
| Features and Benefits: |
This compound was developed by Johnson & Johnson . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: |
1, 5 mg in glass bottle |
| Packaging: |
Store tightly sealed, under desiccant. |
| RIDADR |
NONH for all modes of transport |
| WGK Germany |
WGK 3 |
| Flash Point(F) |
Not applicable |
| Flash Point(C) |
Not applicable |
| Purity |
≥95% (HPLC) |
| Storage Temp. |
−20°C |
| UNSPSC |
12352106 |
